Delivery to Intracellular Targets by Nanosized Particles - Intracellular Delivery: Fundamentals and Applications - page 92

Mehri G, Coleman AW, Devissaguet J Ph and Barratt G M (1996), 'Synthesis and immunostimu-
lating properties of lipophilic ester and ether muramyl peptide derivatives', J Med Chem , 39,
4483-4488.
Melissen P M B, van Vianen W and Bakker-Woudenberg, I A J M (1994), 'Treatment of Klebsiella
pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl
tripeptide phosphatidylethanolamine', Antimicrob Agents Chemother , 38, 147-150.
Mercadal M, Domingo J C, Petriz J C, Garcia J and De Madariaga M M (1999), 'A novel strategy
affords high-yield coupling of antibody to extremities of liposomal surface grafted PEG
chains', Biochim Biophys Acta , 1418, 232-238.
Minko T, Patil M L, Zhang M, Khandare J J, Saad M, Chandna P and Taratula O (2010), 'LHRH-
targeted nanoparticles for cancer therapeutics', Methods Mol Biol , 624, 281-294.
Mitra M, Mandal A K, Chatterjee T K and Das N (2005), 'Targeting of mannosylated liposome
incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticu-
loendothelial systems for the treatment of visceral leishmanias', J Drug Target , 13, 285-293.
Mori K, Ando K and Heymann D (2008), 'Liposomal muramyl tripeptide phosphatidyl etha-
nolamine: a safe and effective agent against osteosarcoma pulmonary metastases', Expert Rev
Anticancer Ther, 8, 151-159.
Morin C, Barratt G M, Fessi H, Devissaguet J-Ph and Puisieux F (1994), 'Improved intracellular
delivery of a muramyldipeptide analog by means of nanocapsules', Int J Immunopharmacol ,
16, 451-456.
Mosqueira VCF, Legrand P, Gulik A, Bourdon O, Gref R, Labarre D and Barratt G (2001),
'Relationship between complement activation, cellular uptake and surface physicochemical
aspects of novel PEG-modified nanocapsules', Biomaterials , 22, 2969-2979.
Mudhakir D, Akita H, Tan E and Harashima H (2008), 'A novel IRQ ligand-modified nano-
carrier targeted to a unique pathway of caveolar endocytic pathway', J Control Rel , 125,
164-173.
Nafee N, Taetz S, Schneider M, Schaefer U F and Lehr C M (2007), 'Chitosan-coated PLGA
nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation
and transfection of antisense oligonucleotides', Nanomedicine, 3, 173-183.
Nahar M, Dubey V, Mishra D, Mishra P K, Dube A and Jain N K (2010), ' In vitro evaluation of
surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral
leishmaniasis', J Drug Target , 18, 93-105.
Oishi M, Nagasaki Y, Itaka K, Nishiyama N and Kataoka K (2005), 'Lactosylated poly(ethylene
glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-
sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells',
J Am Chem Soc, 127, 1624-1625.
Oishi M, Nagasaki Y, Nishiyama N, Itaka K, Takagi M, Shimamoto A, Furuichi Y and Kataoka
K (2007), 'Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosy-
lated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes', Chem
Med Chem, 2, 1290-1297.
Oster C G, Kim N, Grode L, Barbu-Tudoran L, Schaper A K, Kaufmann S H and Kissel T (2005),
'Cationic microparticles consisting of poly(lactide co- glycolide) and polyethylenimine as car-
riers systems for parental DNA vaccination', J Control Rel, 104, 359-377.
Oyen W J, Boerman O C, Storm G, van Bloois L, Koenders E B, Crommelin D J, van der Meer J
W and Corstens F H (1996), 'Labeled Stealth ® liposomes in experimental infection: an alterna-
tive to leukocyte scintigraphy?', Nucl Med Commun , 17, 742-748.
Pagano R E and Huang L (1975), 'Interaction of phospholipid vesicles with cultured mammalian
cells. II. Studies of mechanism', J Cell Biol , 67, 49-60.
Page-Clisson M E, Pinto-Alphandary H, Chachaty E, Couvreur P and Andremont A (1998), 'Drug
targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella ',
Pharm Res , 15, 544-549.
Pakunlu RI, Wang Y, Saad M, Khandare J J, Starovoytov V and Minko T (2006), ' In vitro and
in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug',
J Control Rel , 114, 153-162.